Sabin Llona-Minguez

7PUBLICATIONS
7CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsProteins and peptidesIndustrial biotechnology diagnostics (incl. biosensors)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 03, 2019
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.

Brent D G Page, Nicholas C K Valerie, Roni H G Wright

|Aug 16, 2018
Structure-metabolism-relationships in the microsomal clearance of piperazin-1-ylpyridazines.

Sabin Llona-Minguez, Artin Ghassemian, Pawel Baranczewski

|Jan 19, 2018
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.

Brent D G Page, Nicholas C K Valerie, Roni H G Wright

|Sep 02, 2017
Correction to Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors.

Sabin Llona-Minguez, Andreas Höglund, Artin Ghassemian

|Jul 25, 2017
Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers.

Nahoum G Anthony, Jessica Baiget, Giacomo Berretta

|May 17, 2017
Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors.

Sabin Llona-Minguez, Andreas Höglund, Artin Ghassemian

Pageof 2

Frequent Collaborators

4 joint publications

Nicholas C K Valerie

2 joint publications

Sean G Rudd

1 joint publications

Murray N Robertson

1 joint publications

Oliver B Sutcliffe